Beyond Next Ventures Inc. and DENSO Corporation, announced that they have established OPExPARK Inc., a carve-out to develop the businesses utilizing OPeLiNK®.
OPExPARK will develop and sell systems that integrate information from surgery equipment, produce educational content for surgeons, and offer distribution services.
Business strategies and plans
OPExPARK is a carve-out from the first company that utilized this program
Beyond Next Ventures, which provides incubation funding for technology startups, mainly in life sciences, develops a commercialization acceleration program called BRAVE. This is a commercialization support program for several months focusing on technology seeds at universities and other organizations.
It prepares business strategies and business plans in the initial phase and offers opportunities to strengthen the management team and tap financial resources and networks. OPExPARK is a carve-out from the first company that utilized this program.
DENSO OPeLiNK®
With support from AMED and in cooperation with five universities and 11 companies, DENSO developed OPeLiNK®, an information platform for distributing data gathered from surgical equipment. In function, OPeLiNK® uses visualizations of the data taken from the equipment to share information that was previously difficult to track and communicate widely among medical teams. OPeLiNK® has been installed at Hiroshima University Hospital, Shinshu University Hospital, and Tokyo Women’s Medical University Hospital.
The new company will develop and sell systems that integrate information from surgery equipment by utilizing OPeLiNK®, produce educational content for learning about the latest surgery at any time and anywhere based on the data extracted from the systems, and offer services and educational content for surgeons around the world. The business will start in October.
